APA   Click to copy
Brown, J. D., Shewale, A. R., & Talbert, J. C. (2017). Adherence to rivaroxaban, dabigatran, and apixaban for stroke prevention for newly diagnosed and treatment-naive atrial fibrillation patients: an update using 2013-2014 data. Journal of Managed Care \&Amp; Specialty Pharmacy, 23, 958–967.

Chicago/Turabian   Click to copy
Brown, Joshua D, Anand R Shewale, and Jeffery C Talbert. “Adherence to Rivaroxaban, Dabigatran, and Apixaban for Stroke Prevention for Newly Diagnosed and Treatment-Naive Atrial Fibrillation Patients: an Update Using 2013-2014 Data.” Journal of managed care \& specialty pharmacy 23 (2017): 958–967.

MLA   Click to copy
Brown, Joshua D., et al. “Adherence to Rivaroxaban, Dabigatran, and Apixaban for Stroke Prevention for Newly Diagnosed and Treatment-Naive Atrial Fibrillation Patients: an Update Using 2013-2014 Data.” Journal of Managed Care \&Amp; Specialty Pharmacy, vol. 23, Academy of Managed Care Pharmacy, 2017, pp. 958–67.

@article{brown2017a,
  title = {Adherence to rivaroxaban, dabigatran, and apixaban for stroke prevention for newly diagnosed and treatment-naive atrial fibrillation patients: an update using 2013-2014 data},
  year = {2017},
  journal = {Journal of managed care \& specialty pharmacy},
  pages = {958--967},
  publisher = {Academy of Managed Care Pharmacy},
  volume = {23},
  author = {Brown, Joshua D and Shewale, Anand R and Talbert, Jeffery C}
}